Publikationen in Zusammenarbeit mit Forschern von Scripps Research Institute (11)

2023

  1. Apoptotic cell death in disease—Current understanding of the NCCD 2023

    Cell Death and Differentiation, Vol. 30, Núm. 5, pp. 1097-1154

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

2018

  1. Deregulation of the endocannabinoid system and therapeutic potential of ABHD6 blockade in the cuprizone model of demyelination

    Biochemical Pharmacology, Vol. 157, pp. 189-201

  2. Re-examining the potential of targeting ABHD6 in multiple sclerosis: Efficacy of systemic and peripherally restricted inhibitors in experimental autoimmune encephalomyelitis

    Neuropharmacology, Vol. 141, pp. 181-191

  3. The Lateral Habenula Directs Coping Styles Under Conditions of Stress via Recruitment of the Endocannabinoid System

    Biological Psychiatry, Vol. 84, Núm. 8, pp. 611-623

2017

  1. Building Bridges through Science

    Neuron

2016

  1. Erratum to: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) (Autophagy, 12, 1, 1-222, 10.1080/15548627.2015.1100356

    Autophagy

2010

  1. Effects of the endogenous PPAR-α agonist, oleoylethanolamide on MDMA-induced cognitive deficits in mice

    Synapse, Vol. 64, Núm. 5, pp. 379-389

2005

  1. Uncoupling protein 2 protects dopaminergic neurons from acute 1,2,3,6-methyl-phenyl-tetrahydropyridine toxicity

    Journal of Neurochemistry, Vol. 93, Núm. 2, pp. 493-501

2004

  1. Interaction between the corticotropin-releasing factor system and hypocretins (orexins): A novel circuit mediating stress response

    Journal of Neuroscience, Vol. 24, Núm. 50, pp. 11439-11448

2002

  1. Brain mitochondrial uncoupling protein 2 (UCP2): A protective stress signal in neuronal injury

    Biochemical Pharmacology, Vol. 64, Núm. 3, pp. 363-367